ARCHIVES

Erbitux Plus Chemo Effective For NSCLC; Carboplatin Prevents Testicular Recurrence

This article is from The Cancer Letter archive.

Vol. 31 No. 7 | July 25, 2008

Download PDF Visit The Full Archive

Related Articles

Grant, contract Awards Held Up By Impasse On Appropriations

October 14, 1977

ACS’ Freeman; Declare New War In Cancer; Poor Get Substandard Treatment, Lost Dignity

July 21, 1989

PD-1 Checkpoint Inhibitor Opdivo First to Demonstrate Survival Benefit in Phase III

November 28, 2014

Assurances On Methods For Misconduct Reporting Required

December 1, 1989

Maguire Backs Cancer Program But Insists On New Emphasis for Prevention

January 26, 1979

Cancer Prevention: NSABP Publishes P-1 Data, Finds Risk Of Breast Cancer Cut By 49 Percent

September 18, 1998